Biotech Showcase
Save the date!
Biotech Showcase 2023January 9–11, 2023

Save the date!
Biotech Showcase 2023,
January 9–11, 2023

Seed Showcase: Where Early-Stage Innovators Connect with Transformational Funding

The people, the platform, the opportunities.


Seed Showcase provides investors and pharma companies the opportunity to engage with the up-and-coming young companies. Up to 50 seed-stage companies will be chosen to give a 7-minute company presentation to investors, biopharma companies, and tech transfer offices. 

As part of Biotech Showcase, Seed Showcase will be delivered virtually January 10-12, 2022 and January 17-19, 2022 on partneringONE®.  

One-to-one meetings

Access hundreds of potential partners with our partnering platform, partneringONE®, allowing you to identify prospective partners using advanced search capabilities and manage all your meeting requests in one place. 

Partnering opens on November 30, 2021.

Presenting Companies

Discover innovation through 50+ company presentations from vetted young companies selected to pitch. 

Learn more about presenting at Seed Showcase >>

Panel Discussion

The panel discussion will focus on how to raise funds and position yourself as a young company. Silicon Valley Bank, Hogan Lovells and Novo Nordisk will lead the program 

2022 Panel Discussion to be posted.


Young Early-Stage Companies

As a young company, meeting the right investors and getting in front of the right decision-makers during the most important fund-raising week of the year is crucial. Seed Showcase provides you with the platform to present your company and get noticed by top-tier investors and biopharma companies. 

If you are a qualifying young company, please apply first before registering. If accepted, you will receive further instruction on how to register.

Biopharma Companies & Investors

There is an unmet need in the market to showcase early-stage companies in front of prominent pharma companies and investors. Seed Showcase meets that need and serves as a one-stop-shop to meet and engage with a curated group of early-stage companies. 

Qualified investors are entitled to complimentary registration. If you are a qualified investor, please submit a request here.